Home/Filings/4/0001613377-18-000001
4//SEC Filing

Pascale Adam 4

Accession 0001613377-18-000001

CIK 0000946644other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 11:59 AM ET

Size

5.2 KB

Accession

0001613377-18-000001

Insider Transaction Report

Form 4
Period: 2018-02-13
Pascale Adam
Chief Accounting Officer
Transactions
  • Award

    Options to buy Common Stock

    2018-02-13+123,874123,874 total
    Exercise: $0.37From: 2018-02-13Exp: 2028-02-13Common Stock (123,874 underlying)
Footnotes (1)
  • [F1]This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.

Issuer

HEMISPHERX BIOPHARMA INC

CIK 0000946644

Entity typeother

Related Parties

1
  • filerCIK 0001613377

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 11:59 AM ET
Size
5.2 KB